CPF III-A PT SPV, LLC's Form 4 filing
P3 Health Partners Inc. (PIII) · filed Sep 13, 2023
- Accession no.
- 0001062993-23-017986
- Filed
- Sep 13, 2023, 4:37 PM ET
- Trade date
- Sep 11-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $685.0K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001062993-23-018941 (Oct 4, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| CPF III-A PT SPV, LLCCIK 0001975600 | 10% Owner |
| CPF III PT SPV, LLCCIK 0001975601 | 10% Owner |
| Chicago Pacific Founders UGP III, LLCCIK 0001975658 | 10% Owner |
| Chicago Pacific Founders GP III, L.P.CIK 0001975828 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2023 | Class A Common Stock | PPurchaseAcquired | +90,000 | $2.34F2 | +$210,222 | 49,845,442 | Indirect | |
| Sep 12, 2023 | Class A Common Stock | PPurchaseAcquired | +90,000 | $2.63F4 | +$236,520 | 49,935,442 | Indirect | |
| Sep 13, 2023 | Class A Common Stock | PPurchaseAcquired | +90,000 | $2.65F5 | +$238,221 | 50,025,442 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.36 to $2.9366, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.84, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5.
Referenced by the price of 1 transaction in Table I.